nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—ADRA1B—vas deferens—urinary bladder cancer	0.209	0.552	CbGeAlD
Phenylephrine—CYP1A2—urine—urinary bladder cancer	0.0242	0.0638	CbGeAlD
Phenylephrine—ADRA1D—prostate gland—urinary bladder cancer	0.0183	0.0483	CbGeAlD
Phenylephrine—Tapentadol—UGT2B7—urinary bladder cancer	0.0174	0.862	CrCbGaD
Phenylephrine—ADRA1D—epithelium—urinary bladder cancer	0.0134	0.0355	CbGeAlD
Phenylephrine—ADRA1B—renal system—urinary bladder cancer	0.0127	0.0336	CbGeAlD
Phenylephrine—ADRA1D—urethra—urinary bladder cancer	0.0122	0.0323	CbGeAlD
Phenylephrine—ADRA1A—prostate gland—urinary bladder cancer	0.0105	0.0277	CbGeAlD
Phenylephrine—MAOA—prostate gland—urinary bladder cancer	0.0104	0.0275	CbGeAlD
Phenylephrine—ADRA1D—female reproductive system—urinary bladder cancer	0.00997	0.0263	CbGeAlD
Phenylephrine—MAOA—seminal vesicle—urinary bladder cancer	0.00879	0.0232	CbGeAlD
Phenylephrine—ADRA1A—epithelium—urinary bladder cancer	0.00771	0.0204	CbGeAlD
Phenylephrine—ADRA1A—renal system—urinary bladder cancer	0.00715	0.0189	CbGeAlD
Phenylephrine—MAOA—renal system—urinary bladder cancer	0.00709	0.0187	CbGeAlD
Phenylephrine—MAOA—urethra—urinary bladder cancer	0.00696	0.0184	CbGeAlD
Phenylephrine—CYP1A2—renal system—urinary bladder cancer	0.00591	0.0156	CbGeAlD
Phenylephrine—MAOA—female reproductive system—urinary bladder cancer	0.00568	0.015	CbGeAlD
Phenylephrine—MAOA—vagina—urinary bladder cancer	0.00513	0.0136	CbGeAlD
Phenylephrine—MAOA—lymph node—urinary bladder cancer	0.00332	0.00877	CbGeAlD
Phenylephrine—Epinephrine—TNF—urinary bladder cancer	0.00278	0.138	CrCbGaD
Phenylephrine—Acute coronary syndrome—Gemcitabine—urinary bladder cancer	0.00221	0.00383	CcSEcCtD
Phenylephrine—Extravasation—Epirubicin—urinary bladder cancer	0.0022	0.00381	CcSEcCtD
Phenylephrine—Myocardial infarction—Gemcitabine—urinary bladder cancer	0.0022	0.00381	CcSEcCtD
Phenylephrine—Stinging—Doxorubicin—urinary bladder cancer	0.00219	0.0038	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Fluorouracil—urinary bladder cancer	0.00217	0.00377	CcSEcCtD
Phenylephrine—Angiopathy—Thiotepa—urinary bladder cancer	0.00217	0.00376	CcSEcCtD
Phenylephrine—Immune system disorder—Thiotepa—urinary bladder cancer	0.00216	0.00375	CcSEcCtD
Phenylephrine—Myocardial infarction—Fluorouracil—urinary bladder cancer	0.00216	0.00375	CcSEcCtD
Phenylephrine—Mediastinal disorder—Thiotepa—urinary bladder cancer	0.00216	0.00374	CcSEcCtD
Phenylephrine—Vomiting—Mitomycin—urinary bladder cancer	0.00215	0.00373	CcSEcCtD
Phenylephrine—Arrhythmia—Thiotepa—urinary bladder cancer	0.00214	0.00371	CcSEcCtD
Phenylephrine—Rash—Mitomycin—urinary bladder cancer	0.00213	0.0037	CcSEcCtD
Phenylephrine—Dermatitis—Mitomycin—urinary bladder cancer	0.00213	0.00369	CcSEcCtD
Phenylephrine—Ventricular extrasystoles—Epirubicin—urinary bladder cancer	0.00212	0.00368	CcSEcCtD
Phenylephrine—Headache—Mitomycin—urinary bladder cancer	0.00212	0.00367	CcSEcCtD
Phenylephrine—Mental disorder—Thiotepa—urinary bladder cancer	0.00209	0.00363	CcSEcCtD
Phenylephrine—Sweating increased—Etoposide—urinary bladder cancer	0.00209	0.00363	CcSEcCtD
Phenylephrine—Lacrimation increased—Epirubicin—urinary bladder cancer	0.00208	0.00361	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Cisplatin—urinary bladder cancer	0.00206	0.00357	CcSEcCtD
Phenylephrine—Myocardial infarction—Cisplatin—urinary bladder cancer	0.00205	0.00355	CcSEcCtD
Phenylephrine—Tension—Thiotepa—urinary bladder cancer	0.00204	0.00354	CcSEcCtD
Phenylephrine—Extravasation—Doxorubicin—urinary bladder cancer	0.00203	0.00353	CcSEcCtD
Phenylephrine—Nervousness—Thiotepa—urinary bladder cancer	0.00202	0.00351	CcSEcCtD
Phenylephrine—Nausea—Mitomycin—urinary bladder cancer	0.00201	0.00348	CcSEcCtD
Phenylephrine—Atrioventricular block—Epirubicin—urinary bladder cancer	0.00198	0.00343	CcSEcCtD
Phenylephrine—Ventricular extrasystoles—Doxorubicin—urinary bladder cancer	0.00196	0.00341	CcSEcCtD
Phenylephrine—Vision blurred—Thiotepa—urinary bladder cancer	0.00196	0.0034	CcSEcCtD
Phenylephrine—Skin exfoliation—Methotrexate—urinary bladder cancer	0.00196	0.00339	CcSEcCtD
Phenylephrine—Neck pain—Epirubicin—urinary bladder cancer	0.00194	0.00337	CcSEcCtD
Phenylephrine—Lacrimation increased—Doxorubicin—urinary bladder cancer	0.00193	0.00334	CcSEcCtD
Phenylephrine—Agitation—Thiotepa—urinary bladder cancer	0.00191	0.00332	CcSEcCtD
Phenylephrine—Bradycardia—Cisplatin—urinary bladder cancer	0.00191	0.00331	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Etoposide—urinary bladder cancer	0.00189	0.00327	CcSEcCtD
Phenylephrine—Myocardial infarction—Etoposide—urinary bladder cancer	0.00188	0.00325	CcSEcCtD
Phenylephrine—Cardiac disorder—Gemcitabine—urinary bladder cancer	0.00187	0.00324	CcSEcCtD
Phenylephrine—Skin exfoliation—Epirubicin—urinary bladder cancer	0.00183	0.00318	CcSEcCtD
Phenylephrine—Atrioventricular block—Doxorubicin—urinary bladder cancer	0.00183	0.00317	CcSEcCtD
Phenylephrine—Angiopathy—Gemcitabine—urinary bladder cancer	0.00182	0.00317	CcSEcCtD
Phenylephrine—Pulmonary oedema—Methotrexate—urinary bladder cancer	0.00182	0.00316	CcSEcCtD
Phenylephrine—Immune system disorder—Gemcitabine—urinary bladder cancer	0.00182	0.00315	CcSEcCtD
Phenylephrine—Mediastinal disorder—Gemcitabine—urinary bladder cancer	0.00181	0.00315	CcSEcCtD
Phenylephrine—Visual impairment—Cisplatin—urinary bladder cancer	0.00181	0.00313	CcSEcCtD
Phenylephrine—Hypertension—Thiotepa—urinary bladder cancer	0.0018	0.00312	CcSEcCtD
Phenylephrine—Arrhythmia—Gemcitabine—urinary bladder cancer	0.0018	0.00312	CcSEcCtD
Phenylephrine—Neck pain—Doxorubicin—urinary bladder cancer	0.0018	0.00312	CcSEcCtD
Phenylephrine—Arrhythmia—Fluorouracil—urinary bladder cancer	0.00177	0.00307	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.00176	0.00305	CcSEcCtD
Phenylephrine—Cardiac disorder—Cisplatin—urinary bladder cancer	0.00174	0.00302	CcSEcCtD
Phenylephrine—Pulmonary oedema—Epirubicin—urinary bladder cancer	0.00171	0.00296	CcSEcCtD
Phenylephrine—Skin exfoliation—Doxorubicin—urinary bladder cancer	0.00169	0.00294	CcSEcCtD
Phenylephrine—Immune system disorder—Cisplatin—urinary bladder cancer	0.00169	0.00294	CcSEcCtD
Phenylephrine—Mediastinal disorder—Cisplatin—urinary bladder cancer	0.00169	0.00293	CcSEcCtD
Phenylephrine—Arrhythmia—Cisplatin—urinary bladder cancer	0.00167	0.00291	CcSEcCtD
Phenylephrine—Nervous system disorder—Thiotepa—urinary bladder cancer	0.00167	0.00289	CcSEcCtD
Phenylephrine—Tachycardia—Thiotepa—urinary bladder cancer	0.00166	0.00288	CcSEcCtD
Phenylephrine—Skin disorder—Thiotepa—urinary bladder cancer	0.00165	0.00286	CcSEcCtD
Phenylephrine—Vision blurred—Fluorouracil—urinary bladder cancer	0.00162	0.00282	CcSEcCtD
Phenylephrine—Cardiac disorder—Etoposide—urinary bladder cancer	0.00159	0.00277	CcSEcCtD
Phenylephrine—Pulmonary oedema—Doxorubicin—urinary bladder cancer	0.00158	0.00274	CcSEcCtD
Phenylephrine—Visual disturbance—Methotrexate—urinary bladder cancer	0.00157	0.00272	CcSEcCtD
Phenylephrine—Angiopathy—Etoposide—urinary bladder cancer	0.00156	0.0027	CcSEcCtD
Phenylephrine—Immune system disorder—Etoposide—urinary bladder cancer	0.00155	0.00269	CcSEcCtD
Phenylephrine—Mediastinal disorder—Etoposide—urinary bladder cancer	0.00155	0.00269	CcSEcCtD
Phenylephrine—Eye pain—Epirubicin—urinary bladder cancer	0.00154	0.00267	CcSEcCtD
Phenylephrine—Vision blurred—Cisplatin—urinary bladder cancer	0.00154	0.00267	CcSEcCtD
Phenylephrine—Tremor—Cisplatin—urinary bladder cancer	0.00153	0.00265	CcSEcCtD
Phenylephrine—Paraesthesia—Thiotepa—urinary bladder cancer	0.00153	0.00265	CcSEcCtD
Phenylephrine—Hypertension—Gemcitabine—urinary bladder cancer	0.00151	0.00262	CcSEcCtD
Phenylephrine—Chest pain—Gemcitabine—urinary bladder cancer	0.00149	0.00259	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.00148	0.00257	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00147	0.00254	CcSEcCtD
Phenylephrine—Chest pain—Fluorouracil—urinary bladder cancer	0.00147	0.00254	CcSEcCtD
Phenylephrine—Dysgeusia—Etoposide—urinary bladder cancer	0.00146	0.00254	CcSEcCtD
Phenylephrine—Pain—Thiotepa—urinary bladder cancer	0.00145	0.00252	CcSEcCtD
Phenylephrine—Eye pain—Doxorubicin—urinary bladder cancer	0.00143	0.00247	CcSEcCtD
Phenylephrine—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.0014	0.00243	CcSEcCtD
Phenylephrine—Skin disorder—Gemcitabine—urinary bladder cancer	0.00139	0.00241	CcSEcCtD
Phenylephrine—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00138	0.0024	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.00138	0.00239	CcSEcCtD
Phenylephrine—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00138	0.00239	CcSEcCtD
Phenylephrine—Tachycardia—Fluorouracil—urinary bladder cancer	0.00137	0.00238	CcSEcCtD
Phenylephrine—Urticaria—Thiotepa—urinary bladder cancer	0.00135	0.00234	CcSEcCtD
Phenylephrine—Loss of consciousness—Etoposide—urinary bladder cancer	0.00131	0.00228	CcSEcCtD
Phenylephrine—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00131	0.00227	CcSEcCtD
Phenylephrine—Tachycardia—Cisplatin—urinary bladder cancer	0.0013	0.00226	CcSEcCtD
Phenylephrine—Skin disorder—Cisplatin—urinary bladder cancer	0.00129	0.00224	CcSEcCtD
Phenylephrine—Hypertension—Etoposide—urinary bladder cancer	0.00129	0.00224	CcSEcCtD
Phenylephrine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00129	0.00223	CcSEcCtD
Phenylephrine—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00128	0.00223	CcSEcCtD
Phenylephrine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00127	0.00221	CcSEcCtD
Phenylephrine—Chest pain—Etoposide—urinary bladder cancer	0.00127	0.00221	CcSEcCtD
Phenylephrine—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.00127	0.00221	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.00127	0.00221	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.00126	0.00219	CcSEcCtD
Phenylephrine—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00126	0.00219	CcSEcCtD
Phenylephrine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00125	0.00217	CcSEcCtD
Phenylephrine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00125	0.00217	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00123	0.00214	CcSEcCtD
Phenylephrine—Pain—Gemcitabine—urinary bladder cancer	0.00122	0.00212	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00121	0.0021	CcSEcCtD
Phenylephrine—Pruritus—Thiotepa—urinary bladder cancer	0.0012	0.00209	CcSEcCtD
Phenylephrine—Pain—Fluorouracil—urinary bladder cancer	0.0012	0.00208	CcSEcCtD
Phenylephrine—Paraesthesia—Cisplatin—urinary bladder cancer	0.0012	0.00208	CcSEcCtD
Phenylephrine—Tachycardia—Etoposide—urinary bladder cancer	0.00119	0.00207	CcSEcCtD
Phenylephrine—Dyspnoea—Cisplatin—urinary bladder cancer	0.00119	0.00206	CcSEcCtD
Phenylephrine—Skin disorder—Etoposide—urinary bladder cancer	0.00119	0.00206	CcSEcCtD
Phenylephrine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00118	0.00205	CcSEcCtD
Phenylephrine—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.00118	0.00204	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.00118	0.00204	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00115	0.002	CcSEcCtD
Phenylephrine—Pain—Cisplatin—urinary bladder cancer	0.00114	0.00198	CcSEcCtD
Phenylephrine—Dizziness—Thiotepa—urinary bladder cancer	0.00112	0.00195	CcSEcCtD
Phenylephrine—Urticaria—Fluorouracil—urinary bladder cancer	0.00112	0.00194	CcSEcCtD
Phenylephrine—Paraesthesia—Etoposide—urinary bladder cancer	0.0011	0.0019	CcSEcCtD
Phenylephrine—Dyspnoea—Etoposide—urinary bladder cancer	0.00109	0.00189	CcSEcCtD
Phenylephrine—Vomiting—Thiotepa—urinary bladder cancer	0.00108	0.00187	CcSEcCtD
Phenylephrine—Rash—Thiotepa—urinary bladder cancer	0.00107	0.00186	CcSEcCtD
Phenylephrine—Dermatitis—Thiotepa—urinary bladder cancer	0.00107	0.00186	CcSEcCtD
Phenylephrine—Headache—Thiotepa—urinary bladder cancer	0.00106	0.00185	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00105	0.00183	CcSEcCtD
Phenylephrine—Pain—Etoposide—urinary bladder cancer	0.00104	0.00181	CcSEcCtD
Phenylephrine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00104	0.0018	CcSEcCtD
Phenylephrine—Pruritus—Gemcitabine—urinary bladder cancer	0.00101	0.00175	CcSEcCtD
Phenylephrine—Nausea—Thiotepa—urinary bladder cancer	0.00101	0.00175	CcSEcCtD
Phenylephrine—Pruritus—Fluorouracil—urinary bladder cancer	0.000994	0.00172	CcSEcCtD
Phenylephrine—Visual impairment—Methotrexate—urinary bladder cancer	0.000991	0.00172	CcSEcCtD
Phenylephrine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000981	0.0017	CcSEcCtD
Phenylephrine—Bradycardia—Epirubicin—urinary bladder cancer	0.00098	0.0017	CcSEcCtD
Phenylephrine—Urticaria—Etoposide—urinary bladder cancer	0.000969	0.00168	CcSEcCtD
Phenylephrine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000955	0.00166	CcSEcCtD
Phenylephrine—Angiopathy—Methotrexate—urinary bladder cancer	0.000933	0.00162	CcSEcCtD
Phenylephrine—Immune system disorder—Methotrexate—urinary bladder cancer	0.000929	0.00161	CcSEcCtD
Phenylephrine—Dizziness—Fluorouracil—urinary bladder cancer	0.000929	0.00161	CcSEcCtD
Phenylephrine—Visual impairment—Epirubicin—urinary bladder cancer	0.000928	0.00161	CcSEcCtD
Phenylephrine—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000927	0.00161	CcSEcCtD
Phenylephrine—Vomiting—Gemcitabine—urinary bladder cancer	0.000909	0.00158	CcSEcCtD
Phenylephrine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000907	0.00157	CcSEcCtD
Phenylephrine—Mental disorder—Methotrexate—urinary bladder cancer	0.000901	0.00156	CcSEcCtD
Phenylephrine—Rash—Gemcitabine—urinary bladder cancer	0.000901	0.00156	CcSEcCtD
Phenylephrine—Dermatitis—Gemcitabine—urinary bladder cancer	0.0009	0.00156	CcSEcCtD
Phenylephrine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000899	0.00156	CcSEcCtD
Phenylephrine—Headache—Gemcitabine—urinary bladder cancer	0.000895	0.00155	CcSEcCtD
Phenylephrine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000894	0.00155	CcSEcCtD
Phenylephrine—Vomiting—Fluorouracil—urinary bladder cancer	0.000893	0.00155	CcSEcCtD
Phenylephrine—Rash—Fluorouracil—urinary bladder cancer	0.000886	0.00154	CcSEcCtD
Phenylephrine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000885	0.00154	CcSEcCtD
Phenylephrine—Headache—Fluorouracil—urinary bladder cancer	0.00088	0.00153	CcSEcCtD
Phenylephrine—Dysgeusia—Methotrexate—urinary bladder cancer	0.000877	0.00152	CcSEcCtD
Phenylephrine—Angiopathy—Epirubicin—urinary bladder cancer	0.000874	0.00152	CcSEcCtD
Phenylephrine—Immune system disorder—Epirubicin—urinary bladder cancer	0.00087	0.00151	CcSEcCtD
Phenylephrine—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000868	0.00151	CcSEcCtD
Phenylephrine—Pruritus—Etoposide—urinary bladder cancer	0.000863	0.0015	CcSEcCtD
Phenylephrine—Arrhythmia—Epirubicin—urinary bladder cancer	0.00086	0.00149	CcSEcCtD
Phenylephrine—Visual impairment—Doxorubicin—urinary bladder cancer	0.000859	0.00149	CcSEcCtD
Phenylephrine—Nausea—Gemcitabine—urinary bladder cancer	0.000849	0.00147	CcSEcCtD
Phenylephrine—Vomiting—Cisplatin—urinary bladder cancer	0.000847	0.00147	CcSEcCtD
Phenylephrine—Vision blurred—Methotrexate—urinary bladder cancer	0.000844	0.00146	CcSEcCtD
Phenylephrine—Mental disorder—Epirubicin—urinary bladder cancer	0.000844	0.00146	CcSEcCtD
Phenylephrine—Rash—Cisplatin—urinary bladder cancer	0.00084	0.00146	CcSEcCtD
Phenylephrine—Dermatitis—Cisplatin—urinary bladder cancer	0.000839	0.00146	CcSEcCtD
Phenylephrine—Nausea—Fluorouracil—urinary bladder cancer	0.000835	0.00145	CcSEcCtD
Phenylephrine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000827	0.00143	CcSEcCtD
Phenylephrine—Tension—Epirubicin—urinary bladder cancer	0.000822	0.00143	CcSEcCtD
Phenylephrine—Dysgeusia—Epirubicin—urinary bladder cancer	0.000821	0.00142	CcSEcCtD
Phenylephrine—Nervousness—Epirubicin—urinary bladder cancer	0.000814	0.00141	CcSEcCtD
Phenylephrine—Angiopathy—Doxorubicin—urinary bladder cancer	0.000808	0.0014	CcSEcCtD
Phenylephrine—Dizziness—Etoposide—urinary bladder cancer	0.000807	0.0014	CcSEcCtD
Phenylephrine—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000805	0.0014	CcSEcCtD
Phenylephrine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000803	0.00139	CcSEcCtD
Phenylephrine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000796	0.00138	CcSEcCtD
Phenylephrine—Nausea—Cisplatin—urinary bladder cancer	0.000791	0.00137	CcSEcCtD
Phenylephrine—Vision blurred—Epirubicin—urinary bladder cancer	0.00079	0.00137	CcSEcCtD
Phenylephrine—Mental disorder—Doxorubicin—urinary bladder cancer	0.00078	0.00135	CcSEcCtD
Phenylephrine—Vomiting—Etoposide—urinary bladder cancer	0.000776	0.00135	CcSEcCtD
Phenylephrine—Agitation—Epirubicin—urinary bladder cancer	0.00077	0.00134	CcSEcCtD
Phenylephrine—Rash—Etoposide—urinary bladder cancer	0.000769	0.00133	CcSEcCtD
Phenylephrine—Dermatitis—Etoposide—urinary bladder cancer	0.000769	0.00133	CcSEcCtD
Phenylephrine—Headache—Etoposide—urinary bladder cancer	0.000764	0.00133	CcSEcCtD
Phenylephrine—Chest pain—Methotrexate—urinary bladder cancer	0.000762	0.00132	CcSEcCtD
Phenylephrine—Tension—Doxorubicin—urinary bladder cancer	0.000761	0.00132	CcSEcCtD
Phenylephrine—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000759	0.00132	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000757	0.00131	CcSEcCtD
Phenylephrine—Nervousness—Doxorubicin—urinary bladder cancer	0.000753	0.00131	CcSEcCtD
Phenylephrine—Syncope—Epirubicin—urinary bladder cancer	0.000752	0.0013	CcSEcCtD
Phenylephrine—Palpitations—Epirubicin—urinary bladder cancer	0.000741	0.00129	CcSEcCtD
Phenylephrine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000737	0.00128	CcSEcCtD
Phenylephrine—Vision blurred—Doxorubicin—urinary bladder cancer	0.000731	0.00127	CcSEcCtD
Phenylephrine—Nausea—Etoposide—urinary bladder cancer	0.000725	0.00126	CcSEcCtD
Phenylephrine—Hypertension—Epirubicin—urinary bladder cancer	0.000724	0.00126	CcSEcCtD
Phenylephrine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000717	0.00124	CcSEcCtD
Phenylephrine—Chest pain—Epirubicin—urinary bladder cancer	0.000714	0.00124	CcSEcCtD
Phenylephrine—Agitation—Doxorubicin—urinary bladder cancer	0.000713	0.00124	CcSEcCtD
Phenylephrine—Skin disorder—Methotrexate—urinary bladder cancer	0.00071	0.00123	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000709	0.00123	CcSEcCtD
Phenylephrine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000707	0.00123	CcSEcCtD
Phenylephrine—Syncope—Doxorubicin—urinary bladder cancer	0.000695	0.00121	CcSEcCtD
Phenylephrine—Palpitations—Doxorubicin—urinary bladder cancer	0.000685	0.00119	CcSEcCtD
Phenylephrine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000682	0.00118	CcSEcCtD
Phenylephrine—Shock—Epirubicin—urinary bladder cancer	0.000673	0.00117	CcSEcCtD
Phenylephrine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000671	0.00116	CcSEcCtD
Phenylephrine—Hypertension—Doxorubicin—urinary bladder cancer	0.00067	0.00116	CcSEcCtD
Phenylephrine—Tachycardia—Epirubicin—urinary bladder cancer	0.000668	0.00116	CcSEcCtD
Phenylephrine—Skin disorder—Epirubicin—urinary bladder cancer	0.000664	0.00115	CcSEcCtD
Phenylephrine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000661	0.00115	CcSEcCtD
Phenylephrine—Chest pain—Doxorubicin—urinary bladder cancer	0.00066	0.00115	CcSEcCtD
Phenylephrine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000656	0.00114	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000656	0.00114	CcSEcCtD
Phenylephrine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000652	0.00113	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000631	0.00109	CcSEcCtD
Phenylephrine—Pain—Methotrexate—urinary bladder cancer	0.000625	0.00108	CcSEcCtD
Phenylephrine—Shock—Doxorubicin—urinary bladder cancer	0.000623	0.00108	CcSEcCtD
Phenylephrine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000621	0.00108	CcSEcCtD
Phenylephrine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000618	0.00107	CcSEcCtD
Phenylephrine—Skin disorder—Doxorubicin—urinary bladder cancer	0.000615	0.00107	CcSEcCtD
Phenylephrine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000614	0.00107	CcSEcCtD
Phenylephrine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000612	0.00106	CcSEcCtD
Phenylephrine—Dyspnoea—Epirubicin—urinary bladder cancer	0.00061	0.00106	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000591	0.00102	CcSEcCtD
Phenylephrine—Pain—Epirubicin—urinary bladder cancer	0.000585	0.00101	CcSEcCtD
Phenylephrine—Urticaria—Methotrexate—urinary bladder cancer	0.000581	0.00101	CcSEcCtD
Phenylephrine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000568	0.000986	CcSEcCtD
Phenylephrine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000564	0.000979	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000546	0.000948	CcSEcCtD
Phenylephrine—Urticaria—Epirubicin—urinary bladder cancer	0.000543	0.000943	CcSEcCtD
Phenylephrine—Pain—Doxorubicin—urinary bladder cancer	0.000541	0.000939	CcSEcCtD
Phenylephrine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000539	0.000934	CcSEcCtD
Phenylephrine—Pruritus—Methotrexate—urinary bladder cancer	0.000517	0.000897	CcSEcCtD
Phenylephrine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000504	0.000874	CcSEcCtD
Phenylephrine—Urticaria—Doxorubicin—urinary bladder cancer	0.000503	0.000872	CcSEcCtD
Phenylephrine—Pruritus—Epirubicin—urinary bladder cancer	0.000484	0.00084	CcSEcCtD
Phenylephrine—Dizziness—Methotrexate—urinary bladder cancer	0.000483	0.000839	CcSEcCtD
Phenylephrine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000466	0.000809	CcSEcCtD
Phenylephrine—Vomiting—Methotrexate—urinary bladder cancer	0.000465	0.000806	CcSEcCtD
Phenylephrine—Rash—Methotrexate—urinary bladder cancer	0.000461	0.0008	CcSEcCtD
Phenylephrine—Dermatitis—Methotrexate—urinary bladder cancer	0.00046	0.000799	CcSEcCtD
Phenylephrine—Headache—Methotrexate—urinary bladder cancer	0.000458	0.000794	CcSEcCtD
Phenylephrine—Dizziness—Epirubicin—urinary bladder cancer	0.000452	0.000785	CcSEcCtD
Phenylephrine—Pruritus—Doxorubicin—urinary bladder cancer	0.000448	0.000777	CcSEcCtD
Phenylephrine—Vomiting—Epirubicin—urinary bladder cancer	0.000435	0.000755	CcSEcCtD
Phenylephrine—Nausea—Methotrexate—urinary bladder cancer	0.000434	0.000753	CcSEcCtD
Phenylephrine—Rash—Epirubicin—urinary bladder cancer	0.000431	0.000748	CcSEcCtD
Phenylephrine—Dermatitis—Epirubicin—urinary bladder cancer	0.000431	0.000748	CcSEcCtD
Phenylephrine—Headache—Epirubicin—urinary bladder cancer	0.000429	0.000744	CcSEcCtD
Phenylephrine—Dizziness—Doxorubicin—urinary bladder cancer	0.000419	0.000726	CcSEcCtD
Phenylephrine—Nausea—Epirubicin—urinary bladder cancer	0.000406	0.000705	CcSEcCtD
Phenylephrine—Vomiting—Doxorubicin—urinary bladder cancer	0.000402	0.000698	CcSEcCtD
Phenylephrine—Rash—Doxorubicin—urinary bladder cancer	0.000399	0.000692	CcSEcCtD
Phenylephrine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000399	0.000692	CcSEcCtD
Phenylephrine—Headache—Doxorubicin—urinary bladder cancer	0.000397	0.000688	CcSEcCtD
Phenylephrine—Nausea—Doxorubicin—urinary bladder cancer	0.000376	0.000652	CcSEcCtD
Phenylephrine—MAOA—Biological oxidations—GSTT1—urinary bladder cancer	0.000192	0.0077	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—GSTZ1—urinary bladder cancer	0.000176	0.00705	CbGpPWpGaD
Phenylephrine—CYP1A2—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000174	0.00696	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.000171	0.00687	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—urinary bladder cancer	0.000169	0.00678	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.000169	0.00678	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—GSTO2—urinary bladder cancer	0.000167	0.00669	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—NAT1—urinary bladder cancer	0.000167	0.00669	CbGpPWpGaD
Phenylephrine—CYP1A2—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000165	0.0066	CbGpPWpGaD
Phenylephrine—CYP1A2—Phase II conjugation—NAT2—urinary bladder cancer	0.000156	0.00626	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—UGT2B7—urinary bladder cancer	0.000153	0.00612	CbGpPWpGaD
Phenylephrine—CYP1A2—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000151	0.00603	CbGpPWpGaD
Phenylephrine—ADRA1D—G alpha (12/13) signalling events—RHOA—urinary bladder cancer	0.000144	0.00579	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—CYP4B1—urinary bladder cancer	0.000137	0.00551	CbGpPWpGaD
Phenylephrine—ADRA1B—LPA receptor mediated events—RHOA—urinary bladder cancer	0.000136	0.00546	CbGpPWpGaD
Phenylephrine—CYP1A2—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000136	0.00543	CbGpPWpGaD
Phenylephrine—MAOA—Biological oxidations—GSTP1—urinary bladder cancer	0.000133	0.00534	CbGpPWpGaD
Phenylephrine—CYP1A2—Phase II conjugation—HPGDS—urinary bladder cancer	0.000125	0.00501	CbGpPWpGaD
Phenylephrine—MAOA—Biological oxidations—GSTM1—urinary bladder cancer	0.000122	0.00491	CbGpPWpGaD
Phenylephrine—CYP1A2—Phase II conjugation—GSTT1—urinary bladder cancer	0.000121	0.00486	CbGpPWpGaD
Phenylephrine—ADRA1B—G alpha (12/13) signalling events—RHOA—urinary bladder cancer	0.00012	0.00481	CbGpPWpGaD
Phenylephrine—ADRA1B—LPA receptor mediated events—CXCL8—urinary bladder cancer	0.00012	0.00479	CbGpPWpGaD
Phenylephrine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000118	0.00474	CbGpPWpGaD
Phenylephrine—CYP1A2—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000116	0.00466	CbGpPWpGaD
Phenylephrine—ADRA1B—LPA receptor mediated events—MMP9—urinary bladder cancer	0.000108	0.00433	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (12/13) signalling events—RHOA—urinary bladder cancer	0.000107	0.00427	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000102	0.00408	CbGpPWpGaD
Phenylephrine—ADRA1B—AMPK Signaling—CDKN1A—urinary bladder cancer	0.000101	0.00406	CbGpPWpGaD
Phenylephrine—ADRA1B—LPA receptor mediated events—SRC—urinary bladder cancer	9.97e-05	0.00399	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—NAT2—urinary bladder cancer	9.14e-05	0.00366	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	9.11e-05	0.00365	CbGpPWpGaD
Phenylephrine—CYP1A2—Metapathway biotransformation—NAT2—urinary bladder cancer	9.02e-05	0.00361	CbGpPWpGaD
Phenylephrine—ADRA1A—AMPK Signaling—CDKN1A—urinary bladder cancer	9.01e-05	0.00361	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	8.9e-05	0.00357	CbGpPWpGaD
Phenylephrine—ADRA1B—LPA receptor mediated events—EGFR—urinary bladder cancer	8.74e-05	0.0035	CbGpPWpGaD
Phenylephrine—CYP1A2—Phase II conjugation—GSTP1—urinary bladder cancer	8.4e-05	0.00337	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GSTZ1—urinary bladder cancer	8.16e-05	0.00327	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—NAT1—urinary bladder cancer	7.74e-05	0.0031	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GSTO2—urinary bladder cancer	7.74e-05	0.0031	CbGpPWpGaD
Phenylephrine—CYP1A2—Phase II conjugation—GSTM1—urinary bladder cancer	7.72e-05	0.00309	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	7.31e-05	0.00293	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—HPGDS—urinary bladder cancer	7.31e-05	0.00293	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	7.24e-05	0.0029	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	7.09e-05	0.00284	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—UGT2B7—urinary bladder cancer	7.08e-05	0.00284	CbGpPWpGaD
Phenylephrine—ADRA1B—LPA receptor mediated events—HRAS—urinary bladder cancer	7.01e-05	0.00281	CbGpPWpGaD
Phenylephrine—ADRA1B—AMPK Signaling—TP53—urinary bladder cancer	6.91e-05	0.00277	CbGpPWpGaD
Phenylephrine—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	6.84e-05	0.00274	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	6.78e-05	0.00272	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	6.39e-05	0.00256	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CYP4B1—urinary bladder cancer	6.37e-05	0.00255	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	6.21e-05	0.00249	CbGpPWpGaD
Phenylephrine—ADRA1A—AMPK Signaling—TP53—urinary bladder cancer	6.13e-05	0.00246	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	6.08e-05	0.00244	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	6.08e-05	0.00244	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—SLC19A1—urinary bladder cancer	6.02e-05	0.00241	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	5.91e-05	0.00237	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	5.91e-05	0.00237	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PRSS3—urinary bladder cancer	5.86e-05	0.00235	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	5.3e-05	0.00212	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	5.28e-05	0.00211	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	5.18e-05	0.00208	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	5.18e-05	0.00208	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	5.04e-05	0.00202	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	4.94e-05	0.00198	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	4.94e-05	0.00198	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	4.91e-05	0.00197	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	4.9e-05	0.00196	CbGpPWpGaD
Phenylephrine—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	4.85e-05	0.00194	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—TYMP—urinary bladder cancer	4.69e-05	0.00188	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HDAC4—urinary bladder cancer	4.56e-05	0.00183	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	4.52e-05	0.00181	CbGpPWpGaD
Phenylephrine—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	4.45e-05	0.00178	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—NAT2—urinary bladder cancer	4.24e-05	0.0017	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	4.16e-05	0.00167	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	4.04e-05	0.00162	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—urinary bladder cancer	3.99e-05	0.0016	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—GLI1—urinary bladder cancer	3.82e-05	0.00153	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HDAC4—urinary bladder cancer	3.79e-05	0.00152	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—urinary bladder cancer	3.77e-05	0.00151	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—RRM2—urinary bladder cancer	3.66e-05	0.00147	CbGpPWpGaD
Phenylephrine—MAOA—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.48e-05	0.0014	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—ENO2—urinary bladder cancer	3.39e-05	0.00136	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—HPGDS—urinary bladder cancer	3.39e-05	0.00136	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HDAC4—urinary bladder cancer	3.36e-05	0.00135	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	3.36e-05	0.00135	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—urinary bladder cancer	3.31e-05	0.00133	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GSTT1—urinary bladder cancer	3.29e-05	0.00132	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	3.21e-05	0.00128	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GLI1—urinary bladder cancer	3.17e-05	0.00127	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—urinary bladder cancer	3.13e-05	0.00125	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—CXCL8—urinary bladder cancer	3.08e-05	0.00123	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	3.01e-05	0.00121	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	2.98e-05	0.00119	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—urinary bladder cancer	2.94e-05	0.00118	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	2.85e-05	0.00114	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NAT1—urinary bladder cancer	2.85e-05	0.00114	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GLI1—urinary bladder cancer	2.82e-05	0.00113	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	2.81e-05	0.00112	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—urinary bladder cancer	2.78e-05	0.00111	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—NQO1—urinary bladder cancer	2.73e-05	0.00109	CbGpPWpGaD
Phenylephrine—MAOA—Neuronal System—HRAS—urinary bladder cancer	2.67e-05	0.00107	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	2.66e-05	0.00107	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—RBX1—urinary bladder cancer	2.62e-05	0.00105	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	2.61e-05	0.00105	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—CXCL8—urinary bladder cancer	2.56e-05	0.00102	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TSC1—urinary bladder cancer	2.46e-05	0.000987	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	2.36e-05	0.000947	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	2.35e-05	0.000942	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—JAG1—urinary bladder cancer	2.35e-05	0.00094	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GSTP1—urinary bladder cancer	2.28e-05	0.000913	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—CXCL8—urinary bladder cancer	2.27e-05	0.00091	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	2.22e-05	0.000889	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—RBX1—urinary bladder cancer	2.17e-05	0.000872	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	2.16e-05	0.000867	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—TYMS—urinary bladder cancer	2.12e-05	0.000849	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—NCOR1—urinary bladder cancer	2.09e-05	0.000839	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GSTM1—urinary bladder cancer	2.09e-05	0.000839	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TSC1—urinary bladder cancer	2.04e-05	0.000819	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GPX1—urinary bladder cancer	2.01e-05	0.000804	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—RHOA—urinary bladder cancer	1.98e-05	0.000795	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—ERCC2—urinary bladder cancer	1.97e-05	0.000789	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—JAG1—urinary bladder cancer	1.95e-05	0.00078	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—RBX1—urinary bladder cancer	1.93e-05	0.000774	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—S100B—urinary bladder cancer	1.9e-05	0.000761	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—MTHFR—urinary bladder cancer	1.85e-05	0.000742	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TSC1—urinary bladder cancer	1.82e-05	0.000728	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—RHOA—urinary bladder cancer	1.8e-05	0.000722	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.74e-05	0.000698	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.73e-05	0.000695	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—JAG1—urinary bladder cancer	1.73e-05	0.000693	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	1.73e-05	0.000693	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NCOR1—urinary bladder cancer	1.71e-05	0.000684	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—IL2—urinary bladder cancer	1.66e-05	0.000667	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.66e-05	0.000665	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—RHOA—urinary bladder cancer	1.65e-05	0.000659	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—CXCL8—urinary bladder cancer	1.58e-05	0.000633	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—S100B—urinary bladder cancer	1.58e-05	0.000632	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	1.56e-05	0.000627	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—IL2—urinary bladder cancer	1.51e-05	0.000605	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TERT—urinary bladder cancer	1.5e-05	0.000603	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PPARG—urinary bladder cancer	1.5e-05	0.000601	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—RHOA—urinary bladder cancer	1.49e-05	0.000599	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—RHOA—urinary bladder cancer	1.46e-05	0.000586	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.44e-05	0.000579	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CREBBP—urinary bladder cancer	1.44e-05	0.000578	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NCOR1—urinary bladder cancer	1.42e-05	0.000568	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—S100B—urinary bladder cancer	1.4e-05	0.000561	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—FGFR3—urinary bladder cancer	1.38e-05	0.000553	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—IL2—urinary bladder cancer	1.38e-05	0.000553	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	1.35e-05	0.000541	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ESR1—urinary bladder cancer	1.34e-05	0.000538	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—RHOA—urinary bladder cancer	1.33e-05	0.000532	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CXCL8—urinary bladder cancer	1.31e-05	0.000526	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.28e-05	0.000514	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NCOR1—urinary bladder cancer	1.26e-05	0.000505	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—IL2—urinary bladder cancer	1.25e-05	0.000502	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	1.25e-05	0.000501	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	1.25e-05	0.000501	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TERT—urinary bladder cancer	1.25e-05	0.000501	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.24e-05	0.000498	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—IL2—urinary bladder cancer	1.23e-05	0.000491	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.21e-05	0.000486	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.19e-05	0.000478	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PTGS2—urinary bladder cancer	1.18e-05	0.000473	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CREBBP—urinary bladder cancer	1.18e-05	0.000471	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CXCL8—urinary bladder cancer	1.17e-05	0.000467	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IGF1—urinary bladder cancer	1.16e-05	0.000465	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—EGFR—urinary bladder cancer	1.16e-05	0.000463	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—FGFR3—urinary bladder cancer	1.15e-05	0.000459	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—IL2—urinary bladder cancer	1.11e-05	0.000446	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ESR1—urinary bladder cancer	1.11e-05	0.000446	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TERT—urinary bladder cancer	1.11e-05	0.000445	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—KRAS—urinary bladder cancer	1.09e-05	0.000437	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—RHOA—urinary bladder cancer	1.06e-05	0.000426	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PTEN—urinary bladder cancer	1.03e-05	0.000413	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FGFR3—urinary bladder cancer	1.02e-05	0.000408	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.01e-05	0.000404	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ESR1—urinary bladder cancer	9.89e-06	0.000396	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ERBB2—urinary bladder cancer	9.85e-06	0.000395	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—EP300—urinary bladder cancer	9.82e-06	0.000393	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	9.78e-06	0.000392	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CREBBP—urinary bladder cancer	9.76e-06	0.000391	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IGF1—urinary bladder cancer	9.64e-06	0.000386	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—EGFR—urinary bladder cancer	9.59e-06	0.000384	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CXCL8—urinary bladder cancer	9.34e-06	0.000374	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HRAS—urinary bladder cancer	9.28e-06	0.000372	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—KRAS—urinary bladder cancer	9.06e-06	0.000363	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL2—urinary bladder cancer	8.92e-06	0.000358	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—RHOA—urinary bladder cancer	8.83e-06	0.000354	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CCND1—urinary bladder cancer	8.7e-06	0.000349	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CREBBP—urinary bladder cancer	8.67e-06	0.000347	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IGF1—urinary bladder cancer	8.56e-06	0.000343	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.53e-06	0.000342	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—EGFR—urinary bladder cancer	8.52e-06	0.000341	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MMP9—urinary bladder cancer	8.45e-06	0.000338	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CDKN1A—urinary bladder cancer	8.41e-06	0.000337	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	8.4e-06	0.000337	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PTEN—urinary bladder cancer	8.4e-06	0.000336	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ERBB2—urinary bladder cancer	8.17e-06	0.000327	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.13e-06	0.000326	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—KRAS—urinary bladder cancer	8.05e-06	0.000322	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—EP300—urinary bladder cancer	8.01e-06	0.000321	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—RHOA—urinary bladder cancer	7.84e-06	0.000314	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	7.81e-06	0.000313	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—SRC—urinary bladder cancer	7.79e-06	0.000312	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CXCL8—urinary bladder cancer	7.75e-06	0.000311	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	7.72e-06	0.000309	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	7.72e-06	0.000309	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HRAS—urinary bladder cancer	7.7e-06	0.000309	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL2—urinary bladder cancer	7.41e-06	0.000297	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	7.4e-06	0.000296	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	7.26e-06	0.000291	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ERBB2—urinary bladder cancer	7.26e-06	0.000291	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCND1—urinary bladder cancer	7.22e-06	0.000289	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MMP9—urinary bladder cancer	7.01e-06	0.000281	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CDKN1A—urinary bladder cancer	6.98e-06	0.00028	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MYC—urinary bladder cancer	6.98e-06	0.00028	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PTEN—urinary bladder cancer	6.97e-06	0.000279	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CXCL8—urinary bladder cancer	6.88e-06	0.000276	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HRAS—urinary bladder cancer	6.84e-06	0.000274	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	6.82e-06	0.000274	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—EGFR—urinary bladder cancer	6.82e-06	0.000273	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EP300—urinary bladder cancer	6.65e-06	0.000266	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL2—urinary bladder cancer	6.58e-06	0.000264	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SRC—urinary bladder cancer	6.46e-06	0.000259	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—KRAS—urinary bladder cancer	6.45e-06	0.000258	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCND1—urinary bladder cancer	6.41e-06	0.000257	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MMP9—urinary bladder cancer	6.23e-06	0.00025	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CDKN1A—urinary bladder cancer	6.2e-06	0.000249	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PTEN—urinary bladder cancer	6.19e-06	0.000248	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EP300—urinary bladder cancer	5.9e-06	0.000237	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MYC—urinary bladder cancer	5.79e-06	0.000232	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SRC—urinary bladder cancer	5.74e-06	0.00023	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TP53—urinary bladder cancer	5.73e-06	0.00023	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EGFR—urinary bladder cancer	5.66e-06	0.000227	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	5.53e-06	0.000222	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HRAS—urinary bladder cancer	5.48e-06	0.00022	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—KRAS—urinary bladder cancer	5.35e-06	0.000214	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	5.32e-06	0.000213	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MYC—urinary bladder cancer	5.14e-06	0.000206	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EGFR—urinary bladder cancer	5.03e-06	0.000202	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TP53—urinary bladder cancer	4.76e-06	0.000191	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—KRAS—urinary bladder cancer	4.75e-06	0.00019	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HRAS—urinary bladder cancer	4.55e-06	0.000182	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	4.35e-06	0.000174	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TP53—urinary bladder cancer	4.22e-06	0.000169	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HRAS—urinary bladder cancer	4.04e-06	0.000162	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	3.8e-06	0.000152	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—EP300—urinary bladder cancer	3.62e-06	0.000145	CbGpPWpGaD
